nature.com search

Loading Filters

Showing 1–18 of 18 results

Loading Filters

Research | 24 December 2020 | Open
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
- Manuel Zeitelhofer
- , Milena Z. Adzemovic
- , Christine Moessinger
- , Christina Stefanitsch
- , Carina Strell
- , Lars Muhl
- , Lou Brundin
- , Linda Fredriksson
- , Tomas Olsson
- , Ulf Eriksson
- & Ingrid Nilsson
Scientific Reports 10 , 1–21

Rights & permissionsfor article Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier . Opens in a new window.
Protocols | 23 May 2013
Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease
Nature Protocols 8 , 1149–1154

Rights & permissionsfor article Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease . Opens in a new window.
22 May 1997
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
- Berndt Enholm
- , Karri Paavonen
- , Ari Ristimäki
- , Vijay Kumar
- , Yuji Gunji
- , Juha Klefstrom
- , Laura Kivinen
- , Marikki Laiho
- , Birgitta Olofsson
- , Vladimir Joukov
- , Ulf Eriksson
- & Kari Alitalo
Oncogene 14 , 2475–2483

Rights & permissionsfor article Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia . Opens in a new window.
11 March 2003
PDGF-D is a potent transforming and angiogenic growth factor
- Hong Li
- , Linda Fredriksson
- , Xuri Li
- & Ulf Eriksson
Oncogene 22 , 1501–1510

Rights & permissionsfor article PDGF-D is a potent transforming and angiogenic growth factor . Opens in a new window.
Research | 1 June 1999
Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus
Nature Genetics 22 , 188–191

Rights & permissionsfor article Mutations in the gene encoding 11-<i>cis</i> retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus . Opens in a new window.
Research | 11 April 2001
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
- Erika Bergsten
- , Marko Uutela
- , Xuri Li
- , Kristian Pietras
- , Arne Östman
- , Carl-Henrik Heldin
- , Kari Alitalo
- & Ulf Eriksson
Nature Cell Biology 3 , 512–516

Rights & permissionsfor article PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor . Opens in a new window.
News and Views | 1 August 2002
VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies
- Ulf Eriksson
- & Kari Alitalo
Nature Medicine 8 , 775–777

Rights & permissionsfor article VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies . Opens in a new window.
Research | 1 November 1980
Lung Maturation in Fetuses of Diabetic Rats
Pediatric Research 14 , 1192–1195

Rights & permissionsfor article Lung Maturation in Fetuses of Diabetic Rats . Opens in a new window.
Research | 22 January 2020 | Open
VEGF-B ablation in pancreatic β-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake
- Frank Chenfei Ning
- , Nina Jensen
- , Jiarui Mi
- , William Lindström
- , Mirela Balan
- , Lars Muhl
- , Ulf Eriksson
- , Ingrid Nilsson
- & Daniel Nyqvist
Scientific Reports 10 , 1–13

Rights & permissionsfor article VEGF-B ablation in pancreatic β-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake . Opens in a new window.
Research | 10 October 2019 | Open
Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
- Mirela Balan
- , Marta Trusohamn
- , Frank Chenfei Ning
- , Stefan Jacob
- , Kristian Pietras
- , Ulf Eriksson
- , Per-Olof Berggren
- & Daniel Nyqvist
Scientific Reports 9 , 1–11

Rights & permissionsfor article Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours . Opens in a new window.
Research | 12 March 2018
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
- Pernilla Roswall
- , Matteo Bocci
- , Michael Bartoschek
- , Hong Li
- , Glen Kristiansen
- , Sara Jansson
- , Sophie Lehn
- , Jonas Sjölund
- , Steven Reid
- , Christer Larsson
- , Pontus Eriksson
- , Charlotte Anderberg
- , Eliane Cortez
- , Lao H Saal
- , Christina Orsmark-Pietras
- , Eugenia Cordero
- , Bengt Kristian Haller
- , Jari Häkkinen
- , Ingrid J G Burvenich
- , Elgene Lim
- , Akira Orimo
- , Mattias Höglund
- , Lisa Rydén
- , Holger Moch
- , Andrew M Scott
- , Ulf Eriksson
- & Kristian Pietras
Nature Medicine 24 , 463–473

Rights & permissionsfor article Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling . Opens in a new window.
19 January 2018
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
- Paul Morgan
- , Dean G. Brown
- , Simon Lennard
- , Mark J. Anderton
- , J. Carl Barrett
- , Ulf Eriksson
- , Mark Fidock
- , Bengt Hamrén
- , Anthony Johnson
- , Ruth E. March
- , James Matcham
- , Jerome Mettetal
- , David J. Nicholls
- , Stefan Platz
- , Steve Rees
- , Michael A. Snowden
- & Menelas N. Pangalos
Nature Reviews Drug Discovery 17 , 167–181

Rights & permissionsfor article Impact of a five-dimensional framework on R&D productivity at AstraZeneca . Opens in a new window.
Research | 7 April 2000
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
- Xuri Li
- , Annica Pontén
- , Karin Aase
- , Linda Karlsson
- , Alexandra Abramsson
- , Marko Uutela
- , Gudrun Bäckström
- , Mats Hellström
- , Hans Boström
- , Hong Li
- , Philippe Soriano
- , Christer Betsholtz
- , Carl-Henrik Heldin
- , Kari Alitalo
- , Arne Östman
- & Ulf Eriksson
Nature Cell Biology 2 , 302–309

Rights & permissionsfor article PDGF-C is a new protease-activated ligand for the PDGF α-receptor . Opens in a new window.
Research | 26 September 2012
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes
- Carolina E. Hagberg
- , Annika Mehlem
- , Annelie Falkevall
- , Lars Muhl
- , Barbara C. Fam
- , Henrik Ortsäter
- , Pierre Scotney
- , Daniel Nyqvist
- , Erik Samén
- , Li Lu
- , Sharon Stone-Elander
- , Joseph Proietto
- , Sofianos Andrikopoulos
- , Åke Sjöholm
- , Andrew Nash
- & Ulf Eriksson
Nature 490 , 426–430

Rights & permissionsfor article Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes . Opens in a new window.
Reviews | 1 August 2004
A new oral anticoagulant: the 50-year challenge
Nature Reviews Drug Discovery 3 , 649–659

Rights & permissionsfor article A new oral anticoagulant: the 50-year challenge . Opens in a new window.
Research | 14 March 2010
Vascular endothelial growth factor B controls endothelial fatty acid uptake
- Carolina E. Hagberg
- , Annelie Falkevall
- , Xun Wang
- , Erik Larsson
- , Jenni Huusko
- , Ingrid Nilsson
- , Laurens A. van Meeteren
- , Erik Samen
- , Li Lu
- , Maarten Vanwildemeersch
- , Joakim Klar
- , Guillem Genove
- , Kristian Pietras
- , Sharon Stone-Elander
- , Lena Claesson-Welsh
- , Seppo Ylä-Herttuala
- , Per Lindahl
- & Ulf Eriksson
Nature 464 , 917–921

Rights & permissionsfor article Vascular endothelial growth factor B controls endothelial fatty acid uptake . Opens in a new window.
Research | 1 May 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
- Peter Carmeliet
- , Lieve Moons
- , Aernout Luttun
- , Valeria Vincenti
- , Veerle Compernolle
- , Maria De Mol
- , Yan Wu
- , Françoise Bono
- , Laetitia Devy
- , Heike Beck
- , Dimitri Scholz
- , Till Acker
- , Tina DiPalma
- , Mieke Dewerchin
- , Agnes Noel
- , Ingeborg Stalmans
- , Adriano Barra
- , Sylvia Blacher
- , Thierry Vandendriessche
- , Annica Ponten
- , Ulf Eriksson
- , Karl H. Plate
- , Jean-Michel Foidart
- , Wolfgang Schaper
- , D. Stephen Charnock-Jones
- , Daniel J. Hicklin
- , Jean-Marc Herbert
- , Désiré Collen
- & M. Graziella Persico
Nature Medicine 7 , 575–583

Rights & permissionsfor article Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions . Opens in a new window.
Research | 22 June 2008
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
- Enming J Su
- , Linda Fredriksson
- , Melissa Geyer
- , Erika Folestad
- , Jacqueline Cale
- , Johanna Andrae
- , Yamei Gao
- , Kristian Pietras
- , Kris Mann
- , Manuel Yepes
- , Dudley K Strickland
- , Christer Betsholtz
- , Ulf Eriksson
- & Daniel A Lawrence
Nature Medicine 14 , 731–737

Rights & permissionsfor article Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke . Opens in a new window.

Refine your results by…

Filters

Filter By:

Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier

Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

PDGF-D is a potent transforming and angiogenic growth factor

Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus

PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor

VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies

Lung Maturation in Fetuses of Diabetic Rats

VEGF-B ablation in pancreatic β-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

Impact of a five-dimensional framework on R&D productivity at AstraZeneca

PDGF-C is a new protease-activated ligand for the PDGF α-receptor

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

A new oral anticoagulant: the 50-year challenge

Vascular endothelial growth factor B controls endothelial fatty acid uptake

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters